London, United Kingdom
Qinecsa - formerly MyMeds&Me, is a UK-based company founded in 2012 by seasoned pharma professionals. The company aims to revolutionize the biopharmaceutical industry with its innovative Reportum platform, a digital tool designed to simplify and accelerate the capture and processing of adverse events and product quality data. This platform provides comprehensive pharmacovigilance solutions, aligning with the company's mission to facilitate digital transformation in the sector.
Positioned within the Biopharma, Biotechnology, and Pharmaceutical industries, Qinecsa focuses on enhancing safety insights, a critical aspect for the industry stakeholders. Its long-standing presence and proven platform scalability make it a compelling opportunity for investors who are looking for a high-impact, tech-driven company in the life sciences sector.
While the company has significant potential for growth and impact, it has not recently secured any external investments. Qinecsa remains an intriguing prospect for venture capitalists aiming at tapping into the growing need for advanced pharmacovigilance solutions.
